Therapeutic area
  • Enabling technologies

What the technology does

A novel functional structure of the HIV-1 capsid, which is key to infectivity, has been identified. The technology is a package of tools and data that provide an ideal position for first-in-class HIV therapeutic development.


An entirely novel therapeutic approach to HIV treatment supported by detailed structural information, assay systems amenable to high-throughput screening and prototype blocking compounds with nM affinity.

Main application field

HIV therapy


Therapeutic development


Platform for discovery

Intellectual Property

International phase PCT application, with a priority date of 20/05/2016 (PCT application number PCT/EP2017/062179)


Collaborative development and exclusive or non-exclusive licence

Key Contact

  • In submitting your personal data via this form, you consent to being contacted via the details provided so that your enquiry can be responded to. A backup of your data will be held but only authorised individuals will be able to access your data. If you would like your data to be removed, please email
    Please see our Privacy policy in relation to the personal data you submit to us through this page.
  • We would love to send you information about LifeArc news and events. Please let us know if you would like us to contact you by selecting one of the following options:
All Licensing Opportunities